Page last updated: 2024-10-30

linopirdine and Pulmonary Hypertension

linopirdine has been researched along with Pulmonary Hypertension in 1 studies

linopirdine: acetylcholine releasing drug

Research Excerpts

ExcerptRelevanceReference
" Moreover, oral dosing with flupirtine (30 mg/kg/day) prevented short-term in vivo hypoxia from increasing pulmonary vascular resistance and sensitizing the arteries to acute hypoxia."1.42Role of Kv7 channels in responses of the pulmonary circulation to hypoxia. ( Brennan, S; Ghaly, Y; Gurney, AM; Herget, J; Joshi, S; Mizera, R; Novotna, J; Sedivy, V; Zaloudikova, M, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sedivy, V1
Joshi, S1
Ghaly, Y1
Mizera, R1
Zaloudikova, M1
Brennan, S1
Novotna, J1
Herget, J1
Gurney, AM1

Other Studies

1 other study available for linopirdine and Pulmonary Hypertension

ArticleYear
Role of Kv7 channels in responses of the pulmonary circulation to hypoxia.
    American journal of physiology. Lung cellular and molecular physiology, 2015, Jan-01, Volume: 308, Issue:1

    Topics: Aminopyridines; Analgesics; Animals; Gene Expression Regulation; Hypertension, Pulmonary; Hypoxia; I

2015